Drug Shortage Report for MYLAN-ROSUVASTATIN
Report ID | 30347 |
Drug Identification Number | 02381273 |
Brand name | MYLAN-ROSUVASTATIN |
Common or Proper name | ROSUVASTATIN |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ROSUVASTATIN |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30BL, 100BT, 500BT |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-04-02 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | 2018-04-02 |
Shortage status | Resolved |
Updated date | 2018-04-03 |
Company comments | Discontinued in ID 30342. Mar-2018 last lot 3056799 expires 31-jun-2018 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2018-04-03 | English | Compare |
v4 | 2018-04-02 | French | Compare |
v3 | 2018-04-02 | English | Compare |
v2 | 2017-11-23 | French | Compare |
v1 | 2017-11-23 | English | Compare |
Showing 1 to 5 of 5